Osteoarthritis, HipNCT04322799
A Randomized RSA Study Comparing HXLPE to Conventional Polyethylene in Cemented Total Hip Arthroplasty
A study testing Device: Randomization between prosthetic components in people with Osteoarthritis, Hip and Arthroplasty Complications, run by Umeå University at 1 site in Sweden.
Trial summary
A prospective randomized study comparing two types of cemented acetabular components, a highly-crosslinked polyethylene or conventional polyethylene in total hip arthroplasty. Primary outcome are component wear measured by RSA, secondary outcomes are migration and complications. Read more about this study
- Who is it for?
- Ages 50 years and older
- Conditions the study is for
- Osteoarthritis, Hip, Arthroplasty Complications
- What is being tested?
- Device: Randomization between prosthetic components
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 57 participants
- Where
- 1 siteSweden
- Study dates
- 7 Feb 2013to 30 Jun 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Primary osteoarthritis
- Age 50 years and above
- Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up
Who cannot join
- Rheumatoid Arthritis
- Grossly abnormal hip anatomy (severe dysplasia)
- Fracture sequelae
- Patients who, as judged by the surgeon, are mentally incompetent or are reasonable unlikely to be compliant with the requirements of the study
- Immune suppression or grave systemic illness
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Randomized Controlled RSA Study Comparing the 2nd Generation Highly Cross-linked Polyethylene to Conventional Polyethylene in Cemented Total Hip Arthroplasty
A prospective randomized study comparing two types of cemented acetabular components, a highly-crosslinked polyethylene or conventional polyethylene in total hip arthroplasty. Primary outcome are component wear measured by RSA, secondary outcomes are migration and complications. Patients are evaluated 5 years postoperatively.
Read the detailed description
Background:
Total hip replacements is a cost effective treatment of a symptomatic degenerative hip disease. Cemented total hip replacements are the most common implants in Sweden (Swedish hip registry, 2009).
Wear of ultra high molecular weight polyethylene has been a issue with regard to implant survival. At the time of the shift of the millennium highly cross-linked polyethylene was introduced to the markets. Experimental studies had shown reduction of wear in hip simulator studies (McKellop,1999). Subsequently the intention is to reduce osteolysis and implant loosening. Single surgeon pilot studies in the 1970 (Wroblevski et al. 1996, Oonishi 1998, Grobelaar 1999) were the first clinical series with good results leading to the development of 2nd generation highly cross-linked polyethylenes which is now the almost exclusively used PE worldwide. So far medium term clinical evaluation and laboratory assessment have showed reduced wear and good mechanical properties (Digas et al. 2003, 2004, 2007, Röhrl et al. 2005, 2007, D´Antonio et al. 2005)
Production of highly crosslinked polyethylene (HXLPE) consists of several steps. First the PE material is crosslinked by being subjected to either gamma irradiation of various intensity or electron beam irradiation. The second step is to remove the free radicals created during the irradiation. This is done either by annealing (i.e. warming up the PE to just under its melting temperature) or melting (i.e. warming up the PE to above its melting temperature). Finally, the implant is sterilized either by gamma irradiation or Ethylene Oxide and packed in vacuum or inert atmosphere.There are some possible drawbacks and challenges in the process of cross-linking polyethylene with regard to preserving the mechanical properties and elimination of free radicals (Kurtz et al. 2006, Currier et al. 2007).
Submelt annealing preserves mechanical properties but on the other hand cannot eliminate all free radicals existing in the PE. Retrieval-studies of some 2nd generation highly cross-linked polyethylenes manufactured in this way have shown signs of oxidation. The in-vivo oxidation has been located in the non articulating area such as the circumference of the acetabular liner. It has been discussed that the femoral head may protect the polyethylene against oxidation, and hence prevent the possible negative consequences of remaining free radicals (Currier et al 2007).
Melting the polyethylene eliminates all free radicals but alters the mechanical properties. This has led to PE cracks and implant failure in some clinical studies (Furmanski et al. 2009), whereas it has not been seen in other.
Finally, wear particles of highly crosslinked polyethylene are more often in the submicron size compared to conventional PE. Although these particles have a higher biological activity (Fisher et al. 2006), results of recent studies show however, that the overall risk for osteolysis and aggressiveness of highly cross-linked particles is reduced (Galvin et al. 2007).
Because of differences in the manufacturing processes of highly crosslinking PE between manufacturers (i.e. different GUR used, type of irradiation, intensity of irradiation, postirradiative treatment, type of sterilization and packing, etc, etc) all highly crosslinked polyethylenes differ somewhat from each other. One can not extrapolate results of in vitro or in vivo wear studies of one manufacturer to another. Also, because of these manufacturing differences, fixation characteristics may differ between the various types of HXLPEs. Therefore it is imperative that all new highly crosslinked polyethylenes are subjected to clinical studies of their wear and fixation performance using high accuracy methods before being used extensively.
Methods:
A prospective randomized study comparing acetabular components made of HXLPE or conventional PE in total hip arthroplasty. The study will be conducted at Department of Orthopaedics, Umeå University, Umeå, Sweden.
Aim of study The aim of the study is to compare the wear and migration of a 2nd generation polyethylene from Link with conventional polyethylene in an all-poly cemented acetabular cup of the Lubinus brand using radiostereometric analysis (RSA) with 5-year follow-up.
Hypothesis The H0-hypothesis is that the difference with in wear between HXLPE and conventional PE will not increase up to 5-year follow-up.
Material Patients (age 50 years and above) with primary osteoarthritis between 2013 and 2014 at the orthopaedic department at the county hospital (Lycksele) affiliated to Umeå University hospital, Sweden. Patients were treated with a cemented total hip arthroplasty. At surgery, after the acetabulum was reamed, randomization was performed by opening of a consecutively numbered sealed envelope informing whether a cup made of HXLPE or conventional PE should be inserted. The envelopes were kept far away from the operation theatre and were opened by a research nurse contacted by telephone. Randomization was stratified for gender. Within each stratum there was block randomization with 6 permutations in each block.
Patients have been followed for 5 years postoperatively.
Implants • Acetabular cup Intervention: Link-Ticona GUR 1020 HXLPE, 32 mm inner diameter (Trade name Lubinus® X-LINKed® )
Control: Link-Chirulene GUR 1020 UHMWPE, 32 mm inner diameter (Trade name Lubinus ® UHMWPE)
- Femur stem Test and control: Lubinus® SP II®, CrCo femoral head, 32 mm diameter
Radio Sterometric Analysis (RSA) Radiostereometric analysis measurements will be performed 5 years postoperatively.
Wear will be measured as penetration of the femoral head into the polyethylene in the proximal, proximo-medial (2D pm), proximo-posterior (2D pp), and proximo-medial-posterior (3D) directions. Since the penetration during the initial 3 months represents polyethylene yield or bedding in, wear measurements will be reported from 3 months and up to 5 years postoperatively.
Quality of cup fixation will be measured as rotations of the cup around the three cardinal axes in relation to acetabulum with the postoperative examination as reference.
The RSA measurements will be analysed at Umeå University Hospital. Patient data will be saved in a specific research database at Umeå University Hospital following specific guidelines from the national data security committee.
Ethical approval The study has been approved by the Ethics Committee of Umeå University (Dnr 2011-173-31M, 2018-34-31M).
Sample size With a mean difference in wear at 2 years of 0.1 mm or more (SD ± 0.1) between the groups (p< 0.05), 25 patients in each group will give a power of > 80%. In order to cater for losses during the follow up a total of 57 patients will be enrolled.
Scientific Value All new materials should be monitored closely and introduced in small study groups using a high precision measurement technique. Many markets require such tests before acceptance for general use is given. The new highly crosslinked polyethylene from Link-Ticona is not equivalent to current highly crosslinked polyethylenes on the market, and one can not extrapolate wear results from these other designs.
- Conditions
- Osteoarthritis, Hip, Arthroplasty Complications
- Being tested
- Device: Randomization between prosthetic components
- Keywords
- osteoarthritis, total hip arthroplasty, migration, wear
- Medical subject headings
- Osteoarthritis, Hip, Osteoarthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Device: Randomization between prosthetic componentsProcedure or surgery
Patients are randomized between two types of cup components in total hip arthroplasty. Identical cups made of either highly-crosslinked polyethylene or conventional polyethylene.
| Study group | Role | What they receive |
|---|---|---|
| Acetabular cup HXLPE (Intervention) | Experimental | Randomization to HXLPE acetabular component. Receives: Procedure: Device: Randomization between prosthetic components |
| Acetabular cup Conventional PE (control) | Experimental | Randomization to Coventional PE as control group Receives: Procedure: Device: Randomization between prosthetic components |
What is being measured
The primary outcome is the main question the study is designed to answer.
Magnitude of Polyethylene Wear
The size of the femoral component penetration into the polyethylene measured in millimeters per year and the volumetric annual wear millimetres with radiostereometric (RSA) analysis of radiographs.
Measured: 0-5 years
Secondary outcomes (2)
Magnitude of Cup Migration
Migration measured in millimetres per year with radiostereometric (RSA) analysis of radiographs. Radiostereometric analysis (RSA) is a stereo X-ray technique used in clinical research studies to evaluate micro-motion and wear of orthopaedic implants within bone. The method has a high accuracy and precision. Technical requirements include the need for implanted marker beads and radiograph view angles determined by a calibration cage.
Measured: 0-5 years
Surgical complications
Surgical complications and reapportions during the study period.
Measured: 0-5 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Mar 2020
- Study start7 Feb 2013
- Primary completion4 Dec 2014
- Study completion30 Jun 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for Osteoarthritis, HipStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized controlled trial
- Masking
- None (open label)
- Enrolment
- 57 participants (actual)
Sponsor and investigators
- Lead sponsor
- Umeå University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kjell G Nilsson, Umeå University
- Investigators
- Kjell Nilsson, Professor, Principal investigator, Umeå University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04322799
- Sponsor's protocol ID
- PolyvsHXLPE
- Status last verified
- Mar 2020
- First submitted
- 24 Mar 2020
- Last updated
- 1 Apr 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: On request
Publications
Digas G, Karrholm J, Thanner J, Herberts P. 5-year experience of highly cross-linked polyethylene in cemented and uncemented sockets: two randomized studies using radiostereometric analysis. Acta Orthop. 2007 Dec;78(6):746-54. doi: 10.1080/17453670710014518.
PubMed 18236180D'Antonio JA, Manley MT, Capello WN, Bierbaum BE, Ramakrishnan R, Naughton M, Sutton K. Five-year experience with Crossfire highly cross-linked polyethylene. Clin Orthop Relat Res. 2005 Dec;441:143-50. doi: 10.1097/00003086-200512000-00024.
PubMed 16330997Rajadhyaksha AD, Brotea C, Cheung Y, Kuhn C, Ramakrishnan R, Zelicof SB. Five-year comparative study of highly cross-linked (crossfire) and traditional polyethylene. J Arthroplasty. 2009 Feb;24(2):161-7. doi: 10.1016/j.arth.2007.09.015. Epub 2008 Mar 4.
PubMed 18534491Kurtz SM, Hozack WJ, Purtill JJ, Marcolongo M, Kraay MJ, Goldberg VM, Sharkey PF, Parvizi J, Rimnac CM, Edidin AA. 2006 Otto Aufranc Award Paper: significance of in vivo degradation for polyethylene in total hip arthroplasty. Clin Orthop Relat Res. 2006 Dec;453:47-57. doi: 10.1097/01.blo.0000246547.18187.0b.
PubMed 17031310Rohrl SM, Li MG, Nilsson KG, Nivbrant B. Very low wear of non-remelted highly cross-linked polyethylene cups: an RSA study lasting up to 6 years. Acta Orthop. 2007 Dec;78(6):739-45. doi: 10.1080/17453670710014509.
PubMed 18236179McKellop H, Shen FW, Lu B, Campbell P, Salovey R. Development of an extremely wear-resistant ultra high molecular weight polyethylene for total hip replacements. J Orthop Res. 1999 Mar;17(2):157-67. doi: 10.1002/jor.1100170203.
PubMed 10221831Lerf R, Zurbrugg D, Delfosse D. Use of vitamin E to protect cross-linked UHMWPE from oxidation. Biomaterials. 2010 May;31(13):3643-8. doi: 10.1016/j.biomaterials.2010.01.076. Epub 2010 Feb 9.
PubMed 20144479Bragdon CR, Greene ME, Freiberg AA, Harris WH, Malchau H. Radiostereometric analysis comparison of wear of highly cross-linked polyethylene against 36- vs 28-mm femoral heads. J Arthroplasty. 2007 Sep;22(6 Suppl 2):125-9. doi: 10.1016/j.arth.2007.03.009. Epub 2007 Jul 26.
PubMed 17823030Skoldenberg OG, Rysinska AD, Chammout G, Salemyr M, Mukka SS, Boden H, Eisler T. A randomized double-blind noninferiority trial, evaluating migration of a cemented vitamin E-stabilized highly crosslinked component compared with a standard polyethylene component in reverse hybrid total hip arthroplasty. Bone Joint J. 2019 Oct;101-B(10):1192-1198. doi: 10.1302/0301-620X.101B10.BJJ-2019-0456.R2.
PubMed 31564144Otten V, Wasterlund D, Lindbjorn J, Mertens C, Mukka S, Crnalic S, Nilsson KG. Evaluation of a new cemented highly cross-linked all-polyethylene cup: a prospective and randomised study assessing wear and fixation characteristics using radiostereometric analysis. Hip Int. 2022 Nov;32(6):779-786. doi: 10.1177/1120700021989991. Epub 2021 Feb 10.
PubMed 33566703
Study at a glance
From the registry record, last updated by the sponsor on 1 Apr 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Controlled RSA Study Comparing the 2nd Generation Highly Cross-linked Polyethylene to Conventional Polyethylene in Cemented Total Hip Arthroplasty
- ClinicalTrials.gov ID
- NCT04322799
- Acronym / sponsor ID
- PolyvsHXLPE
- Conditions
- Osteoarthritis, Hip, Arthroplasty Complications
- Keywords
- osteoarthritis, total hip arthroplasty, migration, wear
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 57 participants (actual)
- Lead sponsor
- Umeå UniversityUniversity, hospital or other
- Study start
- 7 Feb 2013 (actual)
- Primary completion
- 4 Dec 2014 (actual)
- Study completion
- 30 Jun 2019 (actual)
- First posted
- 26 Mar 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A prospective randomized study comparing two types of cemented acetabular components, a highly-crosslinked polyethylene or conventional polyethylene in total hip arthroplasty. Primary outcome are component wear measured by RSA, secondary outcomes are migration and complications. Patients are evaluated 5 years postoperatively.
Detailed description
Background:
Total hip replacements is a cost effective treatment of a symptomatic degenerative hip disease. Cemented total hip replacements are the most common implants in Sweden (Swedish hip registry, 2009).
Wear of ultra high molecular weight polyethylene has been a issue with regard to implant survival. At the time of the shift of the millennium highly cross-linked polyethylene was introduced to the markets. Experimental studies had shown reduction of wear in hip simulator studies (McKellop,1999). Subsequently the intention is to reduce osteolysis and implant loosening. Single surgeon pilot studies in the 1970 (Wroblevski et al. 1996, Oonishi 1998, Grobelaar 1999) were the first clinical series with good results leading to the development of 2nd generation highly cross-linked polyethylenes which is now the almost exclusively used PE worldwide. So far medium term clinical evaluation and laboratory assessment have showed reduced wear and good mechanical properties (Digas et al. 2003, 2004, 2007, Röhrl et al. 2005, 2007, D´Antonio et al. 2005)
Production of highly crosslinked polyethylene (HXLPE) consists of several steps. First the PE material is crosslinked by being subjected to either gamma irradiation of various intensity or electron beam irradiation. The second step is to remove the free radicals created during the irradiation. This is done either by annealing (i.e. warming up the PE to just under its melting temperature) or melting (i.e. warming up the PE to above its melting temperature). Finally, the implant is sterilized either by gamma irradiation or Ethylene Oxide and packed in vacuum or inert atmosphere.There are some possible drawbacks and challenges in the process of cross-linking polyethylene with regard to preserving the mechanical properties and elimination of free radicals (Kurtz et al. 2006, Currier et al. 2007).
Submelt annealing preserves mechanical properties but on the other hand cannot eliminate all free radicals existing in the PE. Retrieval-studies of some 2nd generation highly cross-linked polyethylenes manufactured in this way have shown signs of oxidation. The in-vivo oxidation has been located in the non articulating area such as the circumference of the acetabular liner. It has been discussed that the femoral head may protect the polyethylene against oxidation, and hence prevent the possible negative consequences of remaining free radicals (Currier et al 2007).
Melting the polyethylene eliminates all free radicals but alters the mechanical properties. This has led to PE cracks and implant failure in some clinical studies (Furmanski et al. 2009), whereas it has not been seen in other.
Finally, wear particles of highly crosslinked polyethylene are more often in the submicron size compared to conventional PE. Although these particles have a higher biological activity (Fisher et al. 2006), results of recent studies show however, that the overall risk for osteolysis and aggressiveness of highly cross-linked particles is reduced (Galvin et al. 2007).
Because of differences in the manufacturing processes of highly crosslinking PE between manufacturers (i.e. different GUR used, type of irradiation, intensity of irradiation, postirradiative treatment, type of sterilization and packing, etc, etc) all highly crosslinked polyethylenes differ somewhat from each other. One can not extrapolate results of in vitro or in vivo wear studies of one manufacturer to another. Also, because of these manufacturing differences, fixation characteristics may differ between the various types of HXLPEs. Therefore it is imperative that all new highly crosslinked polyethylenes are subjected to clinical studies of their wear and fixation performance using high accuracy methods before being used extensively.
Methods:
A prospective randomized study comparing acetabular components made of HXLPE or conventional PE in total hip arthroplasty. The study will be conducted at Department of Orthopaedics, Umeå University, Umeå, Sweden.
Aim of study The aim of the study is to compare the wear and migration of a 2nd generation polyethylene from Link with conventional polyethylene in an all-poly cemented acetabular cup of the Lubinus brand using radiostereometric analysis (RSA) with 5-year follow-up.
Hypothesis The H0-hypothesis is that the difference with in wear between HXLPE and conventional PE will not increase up to 5-year follow-up.
Material Patients (age 50 years and above) with primary osteoarthritis between 2013 and 2014 at the orthopaedic department at the county hospital (Lycksele) affiliated to Umeå University hospital, Sweden. Patients were treated with a cemented total hip arthroplasty. At surgery, after the acetabulum was reamed, randomization was performed by opening of a consecutively numbered sealed envelope informing whether a cup made of HXLPE or conventional PE should be inserted. The envelopes were kept far away from the operation theatre and were opened by a research nurse contacted by telephone. Randomization was stratified for gender. Within each stratum there was block randomization with 6 permutations in each block.
Patients have been followed for 5 years postoperatively.
Implants • Acetabular cup Intervention: Link-Ticona GUR 1020 HXLPE, 32 mm inner diameter (Trade name Lubinus® X-LINKed® )
Control: Link-Chirulene GUR 1020 UHMWPE, 32 mm inner diameter (Trade name Lubinus ® UHMWPE)
- Femur stem Test and control: Lubinus® SP II®, CrCo femoral head, 32 mm diameter
Radio Sterometric Analysis (RSA) Radiostereometric analysis measurements will be performed 5 years postoperatively.
Wear will be measured as penetration of the femoral head into the polyethylene in the proximal, proximo-medial (2D pm), proximo-posterior (2D pp), and proximo-medial-posterior (3D) directions. Since the penetration during the initial 3 months represents polyethylene yield or bedding in, wear measurements will be reported from 3 months and up to 5 years postoperatively.
Quality of cup fixation will be measured as rotations of the cup around the three cardinal axes in relation to acetabulum with the postoperative examination as reference.
The RSA measurements will be analysed at Umeå University Hospital. Patient data will be saved in a specific research database at Umeå University Hospital following specific guidelines from the national data security committee.
Ethical approval The study has been approved by the Ethics Committee of Umeå University (Dnr 2011-173-31M, 2018-34-31M).
Sample size With a mean difference in wear at 2 years of 0.1 mm or more (SD ± 0.1) between the groups (p< 0.05), 25 patients in each group will give a power of > 80%. In order to cater for losses during the follow up a total of 57 patients will be enrolled.
Scientific Value All new materials should be monitored closely and introduced in small study groups using a high precision measurement technique. Many markets require such tests before acceptance for general use is given. The new highly crosslinked polyethylene from Link-Ticona is not equivalent to current highly crosslinked polyethylenes on the market, and one can not extrapolate wear results from these other designs.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Randomized controlled trial
| Arm | Type | Receives |
|---|---|---|
| Acetabular cup HXLPE (Intervention) | Experimental | Procedure: Device: Randomization between prosthetic componentsRandomization to HXLPE acetabular component. |
| Acetabular cup Conventional PE (control) | Experimental | Procedure: Device: Randomization between prosthetic componentsRandomization to Coventional PE as control group |
Who may qualify
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Primary osteoarthritis
- Age 50 years and above
- Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up
Key exclusion criteria (5 listed)
- Rheumatoid Arthritis
- Grossly abnormal hip anatomy (severe dysplasia)
- Fracture sequelae
- Patients who, as judged by the surgeon, are mentally incompetent or are reasonable unlikely to be compliant with the requirements of the study
- Immune suppression or grave systemic illness
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Device: Randomization between prosthetic componentsPatients are randomized between two types of cup components in total hip arthroplasty. Identical cups made of either highly-crosslinked polyethylene or conventional polyethylene. | Procedure or surgery | Acetabular cup Conventional PE (control), Acetabular cup HXLPE (Intervention) |
Primary outcome
Magnitude of Polyethylene Wear
Time frame: 0-5 years
The size of the femoral component penetration into the polyethylene measured in millimeters per year and the volumetric annual wear millimetres with radiostereometric (RSA) analysis of radiographs.
2 secondary outcomes
Magnitude of Cup Migration
Time frame: 0-5 years
Surgical complications
Time frame: 0-5 years
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Apr 2020.
- Background: PubMed 18236180Digas G, Karrholm J, Thanner J, Herberts P. 5-year experience of highly cross-linked polyethylene in cemented and uncemented sockets: two randomized studies using radiostereometric analysis. Acta Orthop. 2007 Dec;78(6):746-54. doi: 10.1080/17453670710014518.
- Background: PubMed 16330997D'Antonio JA, Manley MT, Capello WN, Bierbaum BE, Ramakrishnan R, Naughton M, Sutton K. Five-year experience with Crossfire highly cross-linked polyethylene. Clin Orthop Relat Res. 2005 Dec;441:143-50. doi: 10.1097/00003086-200512000-00024.
- Background: PubMed 18534491Rajadhyaksha AD, Brotea C, Cheung Y, Kuhn C, Ramakrishnan R, Zelicof SB. Five-year comparative study of highly cross-linked (crossfire) and traditional polyethylene. J Arthroplasty. 2009 Feb;24(2):161-7. doi: 10.1016/j.arth.2007.09.015. Epub 2008 Mar 4.
- Background: PubMed 17031310Kurtz SM, Hozack WJ, Purtill JJ, Marcolongo M, Kraay MJ, Goldberg VM, Sharkey PF, Parvizi J, Rimnac CM, Edidin AA. 2006 Otto Aufranc Award Paper: significance of in vivo degradation for polyethylene in total hip arthroplasty. Clin Orthop Relat Res. 2006 Dec;453:47-57. doi: 10.1097/01.blo.0000246547.18187.0b.
- Background: PubMed 18236179Rohrl SM, Li MG, Nilsson KG, Nivbrant B. Very low wear of non-remelted highly cross-linked polyethylene cups: an RSA study lasting up to 6 years. Acta Orthop. 2007 Dec;78(6):739-45. doi: 10.1080/17453670710014509.
- Background: PubMed 10221831McKellop H, Shen FW, Lu B, Campbell P, Salovey R. Development of an extremely wear-resistant ultra high molecular weight polyethylene for total hip replacements. J Orthop Res. 1999 Mar;17(2):157-67. doi: 10.1002/jor.1100170203.
- Background: PubMed 20144479Lerf R, Zurbrugg D, Delfosse D. Use of vitamin E to protect cross-linked UHMWPE from oxidation. Biomaterials. 2010 May;31(13):3643-8. doi: 10.1016/j.biomaterials.2010.01.076. Epub 2010 Feb 9.
- Background: PubMed 17823030Bragdon CR, Greene ME, Freiberg AA, Harris WH, Malchau H. Radiostereometric analysis comparison of wear of highly cross-linked polyethylene against 36- vs 28-mm femoral heads. J Arthroplasty. 2007 Sep;22(6 Suppl 2):125-9. doi: 10.1016/j.arth.2007.03.009. Epub 2007 Jul 26.
- Background: PubMed 31564144Skoldenberg OG, Rysinska AD, Chammout G, Salemyr M, Mukka SS, Boden H, Eisler T. A randomized double-blind noninferiority trial, evaluating migration of a cemented vitamin E-stabilized highly crosslinked component compared with a standard polyethylene component in reverse hybrid total hip arthroplasty. Bone Joint J. 2019 Oct;101-B(10):1192-1198. doi: 10.1302/0301-620X.101B10.BJJ-2019-0456.R2.
- Derived from this study: PubMed 33566703Otten V, Wasterlund D, Lindbjorn J, Mertens C, Mukka S, Crnalic S, Nilsson KG. Evaluation of a new cemented highly cross-linked all-polyethylene cup: a prospective and randomised study assessing wear and fixation characteristics using radiostereometric analysis. Hip Int. 2022 Nov;32(6):779-786. doi: 10.1177/1120700021989991. Epub 2021 Feb 10.
- Individual participant dataSharing planned: Yes. On request
Related trials for Osteoarthritis, Hip
Not yet recruiting
Effects of Low-Load Blood Flow Restriction Resistance Training With and Without Hip Abductor Strengthening in Patients With Knee Osteoarthritis.(BFR)
Knee Osteoarthritis
Recruiting
FRONT Block for Quality of Recovery After Total Hip Arthroplasty
Osteoarthritis of the Hip, Postoperative Pain
RecruitingObservational study
Post-Market Clinical Follow-up of Intra-Articular Hyaluronic Acid in Hip Osteoarthritis
Hip OA
Not yet recruitingObservational study
Clinical Validation of SMARTDIAGO for Remote Functional Assessment of Musculoskeletal Conditions
Knee Osteoarthristis, Hip Osteoarthritis
RecruitingObservational study
Z1 Hip System: Post-Market Clinical Follow Up Study
Hip Osteoarthritis, Acute Traumatic Fracture of the Femoral Head or Neck
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kjell Nilsson, Professor principal investigator
Umeå University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Device: Randomization between prosthetic components in people with Osteoarthritis, Hip and Arthroplasty Complications, run by Umeå University at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Magnitude of Polyethylene Wear (time frame: 0-5 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04322799, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2020.